Deepak Kamlani

D. A. Davidson & Co. is a dually SEC-registered investment adviser and FINRA broker-dealer headquartered in Great Falls, Montana. The firm was founded in 1935 and is a subsidiary of D.A. Davidson Companies, a financial service holding company. They provide liquidity and execution in small & mid-cap stocks to a wide range of institutional investors, including mutual fund and money managers around the world.

Achelios Therapeutics, Inc. operates as a bio-pharmaceutical development company. It specializes in non-steroidal anti-inflammatory drug. The company was founded by Crist J. Frangakis and is headquartered in Chaple Hill, NC.

Tadiran Communications Ltd. manufactures and designs electronic communications and computing equipment for military and civilian applications. The firm develops reliable, battle-tested products and systems with a multitude of configurations essential for combat environments and tailors them to the needs of its customers around the world. Its products are designed for military and industrial use, which include secure high frequency field radio transmitters, portable computers, and other mobile communications systems. The company is located in Petach-Tikva, Israel.

Mondo Minerals BV manufactures and mines talc. Its solutions include plastic, paints and coatings, life sciences, ceramics, polyester putties, pulp and paper. The company was founded in 1967 and is headquartered in Amsterdam, the Netherlands.

Clayton Associates LLC (Clayton Associates) is a venture capital firm founded in 1996 by Stuart C. McWhorter and R. Clayton McWhorter. The firm is headquartered in Brentwood, Tennessee.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

Validity Sensors, Inc. provides intelligent fingerprint sensing solutions. The company was founded in November 2000 and is headquartered in San Jose, CA.

Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge.

nexVortex, Inc. engages in cloud communication services. It offers hosted voice, contact center, fax, conferencing, and toll-free services. The company was founded by Wesley D. Rogers in 2002 and is headquartered in Herndon, VA.

Global Semiconductor Alliance provides information on and organizes events for the semiconductor industry in order to ensure growth and profitability of the industry. The private company is based in Dallas, TX. The company was founded by Jodi L. Shelton. Jodi L. Shelton has been the CEO since incorporation.

Samsung Co. Ltd. is a South Korean company that manufactures semiconductors, consumer and communication devices.

Part of PepsiCo, Inc., PepsiCo India Holdings Pvt Ltd. is an Indian company that manufactures and supplies soft drinks. The company is based in Gurgaon, India. Ahmed El Shiekh has been the CEO of the company since 2017.

GEO Semiconductor, Inc. provides geometric processing, image signal processing, and video compression solutions to address camera and projection products. Its technology is used in automotive cameras, head-up displays, security IP cameras, smart phone peripherals, projectors and consumer cloud cameras. It specializes in geometric processing, video processing, video compression and cloud software. The company was founded by Paul M. Russo in 2009 and is headquartered in San Jose, CA.

22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle.

Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom.

Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA.

Dropworks, Inc. develops automated platform for performing biological assays. The company was founded by Chris Perkins and Andrew Larsen and is headquartered in Phoenix, AZ.

Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA.

Visgenx, Inc. engages in the development of therapeutics to protect against the loss of sight from retinal disorders. Its product pipeline includes Intravitreal Decitabine and gene therapy. The company was founded by Santosh J. Vetticaden and Robert Martin Emanuele and is headquartered in San Diego, CA.

Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA.

Nereid Therapeutics, Inc. operates as a life sciences venture firm. It translates the potential of biomolecular condensates into life-changing therapeutics. The company was founded by Clifford Brangwynne and Spiros Liras and is headquartered in Cambridge, MA.

The company, co-founded by venture capital firm Apple Tree Partners and New York University cancer researchers Shohei Koide, Ph.D., and Benjamin G. Neel, Ph.D., unites immunotherapy and targeted therapy to expand the power and promise of both approaches for people living with cancer. Aethon Therapeutics, Inc. is based in New York, NY. Part of NYU Langone Medical Center, Aethon Therapeutics, Inc. is a company that creates neoantigens by design to transform cancer treatments into cures. The company's novel anti-drug-peptide conjugate/mhc antibodies are designed to be used in combination with targeted covalent inhibitors of ras, egfr, and other oncogenic driver mutations to mount immune attacks and selectively kill residual cancer cells, including drug-resistant "persister" cells. The company was founded by Benjamin G. Neel, Shohei Koide. The CEO is Rajesh Chopra.